HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Contact sensitivity induced in mice by methylene bisphenyl diisocyanate.

Abstract
An experimental model of contact sensitivity has been developed in C57BL/6 mice using methylene bisphenyl diisocyanate (MDI), a raw material of polyurethane resins. Sensitization through a single epidermal application of 1% MDI solution in ethyl acetate to the backs of the mice resulted in marked ear swelling. The time course of the swelling was characteristic of delayed-type hypersensitivity and the increment of the ear thickness was compatible with that induced by toluene diisocyanate (TDI). Passive transfer of the MDI-induced contact sensitivity was successfully achieved using lymphocytes from the lymph nodes of MDI-sensitized syngeneic mice, and the effector cells were found to be T cells. Cross reaction between MDI and TDI has shown that MDI is not only a potent contact sensitizer but also can form a contact sensitizer group together with TDI.
AuthorsK Tanaka, A Takeoka, F Nishimura, S Hanada
JournalContact dermatitis (Contact Dermatitis) Vol. 17 Issue 4 Pg. 199-204 (Oct 1987) ISSN: 0105-1873 [Print] England
PMID2827956 (Publication Type: Journal Article)
Chemical References
  • Cyanates
  • Isocyanates
  • Toluene 2,4-Diisocyanate
  • 4,4'-diphenylmethane diisocyanate
Topics
  • Administration, Cutaneous
  • Animals
  • Cross Reactions (drug effects)
  • Cyanates (pharmacology, toxicity)
  • Dermatitis, Contact (etiology, immunology)
  • Disease Models, Animal
  • Hypersensitivity, Delayed (chemically induced, immunology)
  • Immunization, Passive
  • Isocyanates
  • Male
  • Mice
  • Mice, Inbred C57BL
  • T-Lymphocytes (immunology)
  • Toluene 2,4-Diisocyanate (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: